Cancer chemotherapy update - Epirubicin, cisplatin, and capecitabine (ECX) regimen

James Waddell, Dominic A. Solimando

Research output: Contribution to journalReview article

Original languageEnglish (US)
Pages (from-to)527-533
Number of pages7
JournalHospital Pharmacy
Volume45
Issue number7
DOIs
StatePublished - Jul 1 2010

Fingerprint

Epirubicin
Cisplatin
Drug Therapy
Neoplasms
Capecitabine

All Science Journal Classification (ASJC) codes

  • Pharmacy
  • Pharmacology
  • Pharmacology (medical)

Cite this

Cancer chemotherapy update - Epirubicin, cisplatin, and capecitabine (ECX) regimen. / Waddell, James; Solimando, Dominic A.

In: Hospital Pharmacy, Vol. 45, No. 7, 01.07.2010, p. 527-533.

Research output: Contribution to journalReview article

@article{57ce753293ff46e8a49643eaeae5d139,
title = "Cancer chemotherapy update - Epirubicin, cisplatin, and capecitabine (ECX) regimen",
author = "James Waddell and Solimando, {Dominic A.}",
year = "2010",
month = "7",
day = "1",
doi = "10.1310/hpj4507-527",
language = "English (US)",
volume = "45",
pages = "527--533",
journal = "Hospital Pharmacy",
issn = "0018-5787",
publisher = "Facts and Comparisons",
number = "7",

}

TY - JOUR

T1 - Cancer chemotherapy update - Epirubicin, cisplatin, and capecitabine (ECX) regimen

AU - Waddell, James

AU - Solimando, Dominic A.

PY - 2010/7/1

Y1 - 2010/7/1

UR - http://www.scopus.com/inward/record.url?scp=77954515311&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77954515311&partnerID=8YFLogxK

U2 - 10.1310/hpj4507-527

DO - 10.1310/hpj4507-527

M3 - Review article

VL - 45

SP - 527

EP - 533

JO - Hospital Pharmacy

JF - Hospital Pharmacy

SN - 0018-5787

IS - 7

ER -